180 Life Sciences Corp. (NASDAQ: ATNF)
$1.4700
-0.0700 ( -4.55% ) 133.8K
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.
Market Data
Open
$1.4700
Previous close
$1.5400
Volume
133.8K
Market cap
$4.45M
Day range
$1.3870 - $1.6050
52 week range
$1.1600 - $17.7500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| d | Other | 1 | Jan 10, 2025 |
| schedule | Other | 1 | Jan 10, 2025 |
| schedule | Other | 2 | Jan 03, 2025 |
| 8-k/a | 8K-related | 14 | Jan 02, 2025 |
| 424b5 | Other | 3 | Dec 30, 2024 |
| s-1/a | Registration statements | 4 | Dec 23, 2024 |
| s-1/a | Registration statements | 3 | Dec 20, 2024 |
| 8-k | 8K-related | 14 | Dec 18, 2024 |
| 8-k | 8K-related | 15 | Dec 12, 2024 |
| 3 | Insider transactions | 1 | Dec 10, 2024 |